Theratechnologies Stock Quote THTX - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.32

Bid

1.23

Ask

1.45

Volume

40,484

1.25 Day's Range 1.37

0.88 52 Week Range 3.9196

Market Cap

60.694M

Previous Close

1.29

Open

1.25

Last Trade

1.32

Last Trade Time

Financial Volume

$ 53,378

VWAP

1.3185

Average Volume (3m)

20,018

Shares Outstanding

45,980,019

Dividend Yield

PE Ratio

-2.53

Earnings Per Share (EPS)

-0.52

Revenue

81.76M

Net Profit

-23.96M

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization... Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.theratech.com

Headquarters

Quebec City, Quebec, Can

Founded

1970

Theratechnologies Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker THTX. The last closing price for Theratechnologies was $1.29. Over the last year, Theratechnologies shares have traded in a share price range of $ 0.88 to $ 3.9196.

Theratechnologies currently has 45,980,019 shares outstanding. The market capitalization of Theratechnologies is $60.69 million. Theratechnologies has a price to earnings ratio (PE ratio) of -2.53.

Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Poster highlights durable disease stabilization lasting beyond treatment completionResults suggest a unique, multimodal mechanism of action that differs from other cancer therapeuticsFavorable...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Theratechnologies Reports on its Annual Meeting of Shareholders

MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...

Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting

First long-term data presentation from Parts 1 and 2 of the Phase 1 clinical trial of sudocetaxel zendusortide in solid tumors Part 3 of Phase 1 trial in advanced ovarian cancer is ongoing...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.13	10.9243697479	1.19	1.37	1.19	11332	1.26595962	CS
4	0.07	5.6	1.25	1.37	1.17	14316	1.25482112	CS
12	-0.02	-1.49253731343	1.34	1.7	1.08	20018	1.35562978	CS
26	-0.28	-17.5	1.6	2.58	1.08	49422	1.65303385	CS
52	-2.4712	-65.1825279595	3.7912	3.9196	0.88	135532	1.80193736	CS
156	-13.08	-90.8333333333	14.4	17.8396	0.88	130129	6.52932537	CS
260	-13.84	-91.2928759894	15.16	17.8396	0.88	160258	8.58800834	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CMTLComtech Telecommunications Corporation	$ 4.07 (87.56%)	91.43M
NLSPNLS Pharmaceutics Ltd	$ 0.2735 (84.42%)	305.35M
ASNSActelis Networks Inc	$ 2.11 (83.48%)	51.37M
RELIReliance Global Group Inc	$ 0.40 (80.18%)	394.85M
LRHCLa Rosa Holdings Corporation	$ 1.78 (71.15%)	52.9M
STISolidion Technology Inc	$ 0.6881 (-64.35%)	16.36M
DMTKDermTech Inc	$ 0.1488 (-55.25%)	10.74M
QMCOQuantum Corporation	$ 0.3752 (-51.90%)	3.14M
ZNTLZentalis Pharmaceuticals Inc	$ 4.135 (-50.72%)	21.58M
AWINAERWINS Technologies Inc	$ 1.74 (-47.90%)	1.05M
RELIReliance Global Group Inc	$ 0.40 (80.18%)	394.85M
NLSPNLS Pharmaceutics Ltd	$ 0.2735 (84.42%)	305.36M
NVDANVIDIA Corporation	$ 135.58 (3.51%)	294.32M
MBIOMustang Bio Inc	$ 0.8517 (13.56%)	291.95M
CRKNCrown Electrokinetics Corporation	$ 0.0548 (-17.10%)	92.39M